Richard Knox
Since he joined NPR in 2000, Knox has covered a broad range of issues and events in public health, medicine, and science. His reports can be heard on NPR's Morning Edition, All Things Considered, Weekend Edition, Talk of the Nation, and newscasts.
Among other things, Knox's NPR reports have examined the impact of HIV/AIDS in Africa, North America, and the Caribbean; anthrax terrorism; smallpox and other bioterrorism preparedness issues; the rising cost of medical care; early detection of lung cancer; community caregiving; music and the brain; and the SARS epidemic.
Before joining NPR, Knox covered medicine and health for The Boston Globe. His award-winning 1995 articles on medical errors are considered landmarks in the national movement to prevent medical mistakes. Knox is a graduate of the University of Illinois and Columbia University. He has held yearlong fellowships at Stanford and Harvard Universities, and is the author of a 1993 book on Germany's health care system.
He and his wife Jean, an editor, live in Boston. They have two daughters.
-
Half of Americans say they've had a major stressful event in the past year, according to a poll by NPR, the Harvard School of Public Health and the Robert Wood Johnson Foundation. Here's how it hurts. -
The federal Medicare program for the elderly and disabled will cover two new drugs that can cure hepatitis C, a liver disease that can cause cancer and lead to death. The drugs are very expensive, but they cure hepatitis C in most cases. The government and insurers are concerned about these costs; three million Americans have hepatitis C, most of whom don't know they have it.
-
Two new drugs for hepatitis C can save lives. They are also wildly expensive, costing $66,000 to $84,000 per person. Insurers face paying billions for treatment, or explicitly rationing vital care. -
There's evidence that many standard treatments for back pain — including surgery, spinal injections and painkillers — are often ineffective and can even worsen and prolong the problem. -
The first in a new class of drugs that can cure the viral infection that is the leading cause of liver failure and liver cancer is poised for a marketing green light from the Food and Drug Administration. More than 3 million Americans have hepatitis C, but most don't know it. -
More than 12 million Americans buy health insurance on their own, and many are getting cancellation notices because their individual coverage does not meet the standards of the Affordable Care Act. This is causing anxiety and anger — especially since most of these people can't get onto the healthcare.gov website to figure out their options for 2014.
-
Seven years ago, Massachusetts launched its own experiment with health insurance exchanges. Those involved in that experiment say it's gone smoothly, and as a result, 97 percent of the state's residents now have health coverage. Some called the program Romneycare; some still do. -
Doctors have debated for years whether a drug that curbed the growth of some prostate cancers caused more serious ones to grow faster. Now, a long-term study calms those fears and raises the possibility that a cheap, generic pill could be used reduce prostate cancer risk. -
The question of how to treat ductal carcinoma in situ is roiling the medical profession, and making for tough choices for women. The condition may never become invasive cancer. But some women choose to have mastectomies rather than live with uncertainty. -
Most people get diagnosed with lung cancer when it's too late to effectively treat it. A federal panel is trying to improve the odds by saying that longtime smokers and former smokers should get annual CT scans to check for lung cancer.
